NCT00000811 |
|
A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children
|
View
|
NCT00000810 |
|
Randomized Phase III Dose-Ranging Open-Label Trial of the Anti-HIV Activity of Delavirdine Mesylate DLV U-90152S
|
View
|
NCT00000809 |
|
Safety and Effectiveness of Two Different Formulations of an HIV Vaccine in Infants Born to HIV-Infected Women
|
View
|
NCT00000808 |
|
A Phase I Study of Safety and Pharmacokinetics of Nevirapine in HIV-1 Infected Pregnant Women and Neonates Born to HIV-1 Infected Mothers
|
View
|
NCT00000807 |
|
Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed AIDS-Related Kaposis Sarcoma After Systemic Chemotherapy
|
View
|
NCT00000806 |
|
A Phase I Randomized DoseFormulation Comparison Study of SC-52151
|
View
|
NCT00000805 |
|
A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus Disease
|
View
|
NCT00000804 |
|
A Randomized Trial of L-735524 An Inhibitor of the HIV Protease Enzyme and Interleukin-2 in Persons Infected With HIV NOTE Only For Patients Who Previously Completed NIAID 93 CC-113
|
View
|
NCT00000803 |
|
A Phase II Double-Blind Study of Delavirdine Mesylate U-90152 in Combination With Zidovudine AZT andor Didanosine ddI Versus AZT and ddI Combination Therapy
|
View
|
NCT00000802 |
|
A Randomized Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim andor Sulfonamides
|
View
|
NCT00000801 |
|
Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma
|
View
|
NCT00000800 |
|
Methadone Effects on Zidovudine ZDV AZT Disposition
|
View
|
NCT00000799 |
|
HPMPC Cidofovir Peripheral CMV Retinitis Trial Protocol
|
View
|
NCT00000798 |
|
A Phase I Safety and Immunogenicity Trial of UBI Microparticulate Monovalent HIV-1 MN Peptide Immunogen in HIV-1 Seronegative Human Subjects
|
View
|
NCT00000797 |
|
Womens Interagency HIV Study WIHS
|
View
|
NCT00000796 |
|
A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis MDRTB in HIV-Infected Patients
|
View
|
NCT00000795 |
|
A Phase I Safety and Immunogenicity Trial of UBI Multivalent HIV-1 Peptide Immunogen in HIV-1 Seronegative Human Subjects
|
View
|
NCT00000794 |
|
Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis
|
View
|
NCT00000793 |
|
A Phase IIIII Double-Blind Study of Amitriptyline and Mexiletine for Painful Neuropathy in HIV Infection
|
View
|
NCT00000792 |
|
A Pharmacologically Guided Phase III Study of Daily Orally Administered Synthetic Hypericin in HIV-Infected Subjects
|
View
|
NCT00000791 |
|
A Phase II Double-Blind Study of Two Doses of SC-49483 in Combination With Zidovudine ZDV Versus ZDV
|
View
|
NCT00000790 |
|
Thalidomide for Treatment of Oral and Esophageal Aphthous Ulcers and HIV Viremia in Patients With HIV Infection
|
View
|
NCT00000789 |
|
A Randomized Comparative Trial of Zidovudine AZT Versus 23-Didehydro-3-Deoxythymidine Stavudine d4T in Children With HIV Infection
|
View
|
NCT00000788 |
|
A Study to Assess the Effect of Concomitant Administration of Fluconazole on the Clinical Pharmacokinetics of Methadone
|
View
|
NCT00000787 |
|
Heterosexual HIV Transmission Study HATS Prospective Cohort Study
|
View
|
NCT00000785 |
|
A Registry of Tuberculosis Cases in the CPCRA
|
View
|
NCT00000784 |
|
A Study of Psychosocial and Behavioral Determinants of Differential Rates of Participant Compliance in CPCRA Protocols
|
View
|
NCT00000783 |
|
Heterosexual HIV Transmission Study HATS
|
View
|
NCT00000782 |
|
A Phase III Study of Delayed-Type Hypersensitivity DTH Reactions to Intradermal HIV Envelope Antigen
|
View
|
NCT00000781 |
|
A Randomized Double-Blind Four-Arm Study Comparing Combination Nucleoside Alternating Nucleoside and Triple-Drug Therapy for the Treatment of Advanced HIV Disease CD4 50mm3
|
View
|
NCT00000780 |
|
A Pre-Enrollment Protocol for HIV-Infected Adolescents
|
View
|
NCT00000779 |
|
A Phase I Comparative Blinded Trial of Several HIV-1 Derived Immunogens in Infected Individuals With 500 CD4 Cellsmm3
|
View
|
NCT00000778 |
|
A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity Tolerance and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and Levofloxacin
|
View
|
NCT00000777 |
|
Active Immunization of HIV-1 Infected Pregnant Women With CD4 Lymphocyte Counts 400mm3 A Phase I Study of Safety and Immunogenicity of VaxSyn Recombinant gp160 NOTE Some Patients Receive Placebo
|
View
|
NCT00000776 |
|
Dexamethasone in Cryptococcal Meningitis
|
View
|
NCT00000775 |
|
A Phase I Safety and Immunogenicity Trial of UBI SynVac HIV-1 MN Octameric V3 Peptide Vaccine
|
View
|
NCT00000774 |
|
A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers
|
View
|
NCT00000773 |
|
Phase I Safety and Pharmacokinetics Study of Microparticulate Atovaquone m-Atovaquone 566C80 in HIV-Infected and Perinatally Exposed Infants and Children
|
View
|
NCT00000772 |
|
A Phase I Open-Label Study of the Safety Tolerance and Pharmacokinetic Interactions of Combination Didanosine and Ribavirin in HIV-Positive Individuals
|
View
|
NCT00000771 |
|
A Double-Blind Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis in Patients With Advanced HIV Disease and CD4 Counts Under 150 Cellsmm3
|
View
|
NCT00000770 |
|
A Comparative Study of a Combination of Zidovudine Didanosine and Double-Blinded Nevirapine Versus a Combination of Zidovudine and Didanosine
|
View
|
NCT00000769 |
|
A Phase III Study of Recombinant Interleukin-4 in AIDS and Kaposis Sarcoma
|
View
|
NCT00000768 |
|
A Randomized Comparative Pharmacokinetic Study of Oral Ganciclovir After Treatment With Intravenous Ganciclovir for Cytomegalovirus Gastrointestinal Disease in AIDS Patients
|
View
|
NCT00000767 |
|
A Multicenter Randomized Placebo-Controlled Double-Blind Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV-1 IIIB EnvGagPol Vaccine TBC-3B
|
View
|
NCT00000766 |
|
CMV Retinitis Retreatment Trial
|
View
|
NCT00000765 |
|
Pilot Study to Evaluate the Efficacy of Zidovudine in Preventing CD4 Lymphocyte Decline in Patients With Primary HIV Infection One Treatment Arm Receives Placebo
|
View
|
NCT00000764 |
|
Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection
|
View
|
NCT00000763 |
|
A Phase I Study of TNP-470 in the Treatment of AIDS-Associated Kaposis Sarcoma
|
View
|
NCT00000762 |
|
A Placebo-Controlled Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Envelope Proteins of HIV-1 gp160 and gp120 in Children 1 Month Old With Asymptomatic HIV Infection
|
View
|
NCT00000761 |
|
Phase III Study of Recombinant Human Interferon-gamma rIFN-gamma in HIV-Infected Children
|
View
|
NCT00000760 |
|
A Randomized Study of Activity Safety and Tolerance of Oral Ro 24-7429 Tat Antagonist in Patients With HIV Infection
|
View
|
NCT00000759 |
|
Neurodevelopmental and Neurological Study of Infants and Children With HIV-1 Infection and AIDS in Clinical Trials
|
View
|
NCT00000758 |
|
A Phase III Randomized Trial of Topical Vaginal Fluorouracil 5-Fluorouracil 5-FU Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women
|
View
|
NCT00000757 |
|
A Phase I Multicenter Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160
|
View
|
NCT00000756 |
|
Evaluation of the Safety and Tolerance of Immunotherapy With Autologous Ex-Vivo Expanded HIV-Specific Cytotoxic T-Cells in HIV-Infected Patients With CD4 Counts Between 100-400mm3
|
View
|
NCT00000755 |
|
A Phase III Trial of Vaccine Therapy of HIV-1 Infected Individuals With 50-500 CD4 Cellsmm3
|
View
|
NCT00000754 |
|
A Randomized Phase II Study of Two Doses of Interferon Alfa-2a IFN Alfa-2a in Combination With Zidovudine AZT and Dideoxycytidine ddC Versus AZT and ddC Only in Patients With HIV Infection and Less Than 400 CD4 Cellsmm3
|
View
|
NCT00000753 |
|
A Phase I Concentration-Targeted Multidose Study of Atevirdine Mesylate U-87201E AZT and ddI or ddC
|
View
|
NCT00000752 |
|
Preventing Frequent Sinus Infections in HIV-Infected Patients
|
View
|
NCT00000751 |
|
A Phase III Randomized Double-Blind Controlled Study of the Use of Anti-HIV Immune Serum Globulin HIVIG for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine AZT
|
View
|
NCT00000750 |
|
A Phase III Study to Evaluate the Safety Tolerance and Efficacy of Early Treatment With Zidovudine AZT in Asymptomatic Infants With HIV Infection
|
View
|
NCT00000749 |
|
A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 200 Mcg of gp120 CHO BIOCINE in MF59 Emulsion Versus the Emulsion Control Three Injections at 0 1 and 6 Months
|
View
|
NCT00000748 |
|
A Randomized Comparative Prospective Study of Daily Trimethoprim Sulfamethoxazole TMS and Thrice-Weekly TMS for Prophylaxis Against PCP in HIV-Infected Patients
|
View
|
NCT00000747 |
|
An Open-Label Pilot Study to Evaluate the Development of Resistance to Nevirapine BI-RG-587 in HIV-Infected Patients With CD4 Cell Count 500mm3
|
View
|
NCT00000746 |
|
A Phase I Multicenter Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine HIVAC-1e in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines
|
View
|
NCT00000745 |
|
A Phase I Multicenter Randomized Double-Blind Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160
|
View
|
NCT00000744 |
|
A Randomized Prospective Double-Blind Study Comparing Fluconazole With Placebo for Primary and Secondary Prophylaxis of Mucosal Candidiasis in HIV-Infected Women
|
View
|
NCT00000743 |
|
A Phase I Dose-Escalating Safety and Tolerance Study of sCD4-PE40 in HIV-Infected Persons
|
View
|
NCT00000742 |
|
A Phase I Concentration-Controlled Trial to Assess the Safety Tolerance Pharmacokinetics and Development of Decreased HIV-1 Susceptibility to the Combination of Atevirdine Mesylate U-87201E Zidovudine AZT and Didanosine ddI
|
View
|
NCT00000741 |
|
The Safety and Effectiveness of Methylprednisolone in the Treatment of Pneumocystis Carinii Pneumonia PCP in Children With AIDS
|
View
|
NCT00000740 |
|
Escalating Multiple-Dose Safety and Tolerance of WR 6026 Hydrochloride in HIV-Infected Subjects
|
View
|
NCT00000739 |
|
Comparison of Two Dosage Regimens of Oral Dapsone for Prophylaxis of Pneumocystis Carinii Pneumonia in Pediatric HIV Infection
|
View
|
NCT00000738 |
|
Randomized Double-Blind Placebo-Controlled Trial of Nimodipine for the Neurological Manifestations of HIV-1
|
View
|
NCT00000737 |
|
A Phase III Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting Syndrome
|
View
|
NCT00000736 |
|
Safety and Efficacy of Zidovudine for Asymptomatic HIV-Infected Individuals
|
View
|
NCT00000735 |
|
A Clinical Trial To Evaluate the Toxicity and Antiviral Effects of a Range of Doses of Ampligen in p24 Antigen Positive HIV-Infected Patients With AIDS or ARC
|
View
|
NCT00000734 |
|
Evaluation of the Interaction Between High Dose SulfamethoxazoleTrimethoprim and Zidovudine
|
View
|
NCT00000733 |
|
Phase I Pharmacokinetic and Tolerance Study of Ribavirin in Human Immunodeficiency Virus HIV - Infected Patients
|
View
|
NCT00000732 |
|
Evaluation of the Interaction Between Low Dose Sulfamethoxazole-Trimethoprim and Zidovudine
|
View
|
NCT00000731 |
|
Evaluation of the Interaction Between Acetaminophen and Zidovudine
|
View
|
NCT00000730 |
|
Comparison of Three Treatments for Pneumocystis Pneumonia in AIDS Patients
|
View
|
NCT00000729 |
|
A Multicenter Study To Determine Foscarnet Dose Response in HIV Infected Patients With PGL andor Constitutional Disease
|
View
|
NCT00000728 |
|
Phase I Trial of the Combination of Zidovudine and Recombinant Interleukin-2 in Patients With Persistent Generalized Lymphadenopathy
|
View
|
NCT00000727 |
|
A Controlled Comparative Trial of Sulfamethoxazole-Trimethoprim Versus Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients Receiving Azidothymidine AZT
|
View
|
NCT00000726 |
|
Foscarnet Treatment of Serious CMV Retinitis Infection in Patients With Acquired Immunodeficiency Syndrome
|
View
|
NCT00000725 |
|
A Phase I Study of AZT and Human Interferon Alpha Recombinant Alpha-2A and Lymphoblastoid in the Treatment of AIDS-Associated Kaposis Sarcoma
|
View
|
NCT00000724 |
|
A Study of Trimetrexate With Leucovorin Rescue for AIDS Patients Who Are Refractory to Standard Therapies for Pneumocystis Carinii Pneumonia
|
View
|
NCT00000723 |
|
The Use of Chemotherapy Plus Radiotherapy Plus Azidothymidine in Patients With AIDS-Related Lymph Node Cancer
|
View
|
NCT00000722 |
|
Aerosols in the Treatment of Pneumocystis Pneumonia A Pilot Study Quantitating the Deposition of Aerosolized Pentamidine as Delivered in ACTG 040 and Comparing Its Toxicity With Parenteral Pentamidine Therapy
|
View
|
NCT00000721 |
|
An Escalating Dose Tolerance Trial of BG8962 rCD4 in Patients Who Are HIV Antibody Positive
|
View
|
NCT00000720 |
|
A Double-Blind Placebo-Controlled Trial To Evaluate Intravenous Gamma Globulin in Children With Symptomatic HIV Infection Receiving Zidovudine
|
View
|
NCT00000719 |
|
A Trial of Alternating 23-Dideoxycytidine and Zidovudine in the Treatment of Patients With Advanced HIV Disease
|
View
|
NCT00000718 |
|
A Clinical Trial of Alternating and Intermittent Regimens of 23-Dideoxycytidine and 3-Azido-3-Deoxythymidine in the Treatment of Patients With AIDS and Advanced ARC
|
View
|
NCT00000717 |
|
The Safety and Efficacy of Clindamycin and Primaquine in the Treatment of Mild - Moderate Pneumocystis Carinii Pneumonia in Patients With AIDS
|
View
|
NCT00000716 |
|
A Multicenter Trial To Evaluate Oral Retrovir in the Treatment of Children With Symptomatic HIV Infection
|
View
|
NCT00000715 |
|
A Controlled Trial Comparing the Efficacy of Aerosolized Pentamidine and ParenteralOral Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia in AIDS
|
View
|
NCT00000714 |
|
An Open Prospective Multicenter Study of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia PCP and Serious Intolerance to Approved Therapies
|
View
|
NCT00000713 |
|
A Phase I Clinical Trial To Evaluate the Toxicity Antiviral and Immunomodulatory Effects of a Range of Doses of Ampligen in HIV-Infected Subjects
|
View
|
NCT00000712 |
|
A Multicenter Double Blind Comparative Study of Zidovudine Alone Versus Zidovudine and Acyclovir as Treatment for HIV-Infected Patients With CD4 Counts Less Than 200 Cellsmm3
|
View
|
NCT00000711 |
|
Granulocyte-Macrophage Colony-Stimulating Factor and Zidovudine A Phase I Study of Concurrent Administration in Patients With AIDS and Severe ARC
|
View
|
NCT00000710 |
|
A Phase I Safety Efficacy and Pharmacokinetic Study of 23-Dideoxyinosine ddI Administered Twice Daily to Patients With AIDS or AIDS Related Complex
|
View
|
NCT00000709 |
|
An Open Trial of Zidovudine AZT Treatment of the AIDS Dementia Complex in Patients With AIDS or Low CD4 Lymphocyte Counts
|
View
|
NCT00000708 |
|
Multi-center Comparison of Fluconazole UK-49858 and Amphotericin B as Treatment for Acute Cryptococcal Meningitis
|
View
|
NCT00000707 |
|
Aerosols in the Treatment of Asymptomatic Pneumocystis Pneumonia A Pilot Study Assessing the Effectiveness of Aerosolized Pentamidine as Treatment of Subclinical Pneumocystis Infection in Patients With No Clinical Symptoms
|
View
|
NCT00000706 |
|
Influence of Probenecid and Quinine on the Pharmacokinetics of Azidothymidine
|
View
|
NCT00000705 |
|
Safety and Effectiveness of Azidothymidine AZT in HIV-Positive Patients With Hemophilia
|
View
|
NCT00000704 |
|
A Multicenter Dose Ranging Clinical Trial of 23-Dideoxycytidine in the Treatment of Patients With AIDS and Advanced ARC
|
View
|
NCT00000703 |
|
Chemotherapy and Azidothymidine With or Without Radiotherapy for High Grade Lymphoma in AIDS-Risk Group Members
|
View
|
NCT00000702 |
|
A Multicenter Placebo-Controlled Double-Blind Trial to Evaluate Azidothymidine AZT Treatment of the AIDS Dementia Complex and Central Nervous System CNS Human Immunodeficiency Virus HIV Infection
|
View
|
NCT00000701 |
|
A Phase I Evaluation of Azidothymidine AZT in Children With Acquired Immune Deficiency Syndrome AIDS or AIDS Related Complex ARC
|
View
|
NCT00000700 |
|
A Multi-Center Clinical Trial To Evaluate Azidothymidine AZT in the Treatment of Human Immunodeficiency Virus HIV Infection in Patients With AIDS Post First Episode PCP
|
View
|
NCT00000699 |
|
A Phase III Trial of Ribavirin With Escalation Isoprinosine in Asymptomatic HIV-Viremic Patients
|
View
|
NCT00000698 |
|
A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis
|
View
|
NCT00000697 |
|
A Study of Foscarnet in the Treatment of Cytomegalovirus CMV of the Eyes in Patients With AIDS Who Cannot Use Ganciclovir
|
View
|
NCT00000696 |
|
A Phase III Open Label Study To Evaluate the Antiviral Potential of Combination Low-Dose Therapy With Zidovudine and Interferon-Alpha 2A in Patients With Symptomatic HIV Disease
|
View
|
NCT00000695 |
|
Open Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and Interferon-Beta in Patients With AIDS Related Kaposis Sarcoma
|
View
|
NCT00000694 |
|
A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor rHuGM-CSF Recombinant Alpha Interferon and Azidothymidine AZT in AIDS-Associated Kaposis Sarcoma
|
View
|
NCT00000693 |
|
Suppression of Cytomegalovirus Retinitis Utilizing High Dose Intravenous Acyclovir and Oral Zidovudine in Patients With AIDS
|
View
|
NCT00000692 |
|
Phase I Rising Dose Tolerability Study of SC-48334 in Patients With Acquired Immunodeficiency Syndrome AIDS and Advanced AIDS Related Complex
|
View
|
NCT00000691 |
|
A Phase II Dose-Ranging Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure
|
View
|
NCT00000690 |
|
Single Dose Pharmacokinetics of Oral Dextran Sulfate UA001 and Intravenous Dextran Sulfate in Healthy Volunteers
|
View
|
NCT00000689 |
|
Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor GM-CSF in AIDS-Associated Large Cell Immunoblastic and Small Non-cleaved Lymphoma
|
View
|
NCT00000688 |
|
A Randomized Controlled Study of Intravenous Ganciclovir Therapy for Peripheral Cytomegalovirus Retinitis in Patients With AIDS
|
View
|
NCT00000687 |
|
Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associated Kaposis Sarcoma
|
View
|
NCT00000686 |
|
A Study of d4T in Patients With AIDS or AIDS-Related Complex Who Cannot Take AZT
|
View
|
NCT00000685 |
|
A Study of Zidovudine in HIV-Infected Patients With Kidney Problems
|
View
|
NCT00000684 |
|
Continuous High-Dose Intravenous Dextran Sulfate in Human Immunodeficiency Virus-Infected Individuals
|
View
|
NCT00000683 |
|
A Phase I Multicenter Randomized Double-Blind Trial to Evaluate the Safety and Immunogenicity of Recombinant Vaccinia Virus Expressing the Envelope Glycoproteins of Human Immunodeficiency Virus
|
View
|
NCT00000682 |
|
A Randomized Unblinded Trial of Zidovudine Versus ddC in the Treatment of Patients Status Post PCP Who Received Long-Term Zidovudine Therapy in Protocol ACTG 002
|
View
|
NCT00000681 |
|
A Phase I Study of the Combination of Recombinant GM-CSF AZT and Chemotherapy ABV Adriamycin Bleomycin Vincristine in AIDS and Kaposis Sarcoma
|
View
|
NCT00000680 |
|
A Phase I Study of Autologous Activated CD8 Lymphocytes Expanded In Vitro and Infused With or Without Recombinant Interleukin-2 to Patients With AIDS or Severe ARC
|
View
|
NCT00000679 |
|
Ro 24-2027 A Randomized Double-Blind Comparative Study of Dideoxycytidine ddC Versus Zidovudine AZT in Patients With AIDS or Advanced ARC
|
View
|
NCT00000678 |
|
Dideoxycytidine Ro 24-2027 A Randomized Open-Label Comparative Study of Dideoxycytidine ddC Versus Zidovudine AZT in Patients With AIDS or Advanced ARC Who Have Received Long-Term AZT Therapy
|
View
|
NCT00000677 |
|
SCH 39304 as Therapy for Acute Cryptococcal Meningitis in HIV-Infected Patients Followed by Maintenance Therapy
|
View
|
NCT00000676 |
|
Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex A Nested Study of ACTG 081
|
View
|
NCT00000675 |
|
A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4 Immunoglobulin rCd4-IgG Administered by Intravenous Bolus in Patients With AIDS and AIDS Related Complex
|
View
|
NCT00000674 |
|
A Pilot Study of Oral Clindamycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDS
|
View
|
NCT00000673 |
|
A Phase III Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS Patients With Active CMV Retinitis Who Are Intolerant of Systemic Therapy
|
View
|
NCT00000672 |
|
An Efficacy Study of 23-Dideoxyinosine ddI BMY-40900 Administered Orally Twice Daily to Zidovudine Intolerant Patients With AIDS or AIDS-Related Complex
|
View
|
NCT00000671 |
|
A Phase II Efficacy Study Comparing 23-Dideoxyinosine ddI BMY-40900 and Zidovudine Therapy of Patients With HIV Infection Who Have Been on Long Term Zidovudine Treatment
|
View
|
NCT00000670 |
|
Safety and Tolerance of Zidovudine With Probenecid and the Effect of Probenecid on Zidovudine Pharmacokinetics Over Four Weeks
|
View
|
NCT00000669 |
|
A Phase I Safety and Pharmacokinetics Study of 23-Dideoxyinosine ddI Administered Twice Daily to Infants and Children With AIDS or Symptomatic HIV Infection
|
View
|
NCT00000668 |
|
A Phase I Pharmacokinetic and Tolerance Study of 28-Day Regimens of Oral Ganciclovir
|
View
|
NCT00000667 |
|
A Phase III Dose Escalation Study of Intradermal gp160 to Evaluate Safety Delayed Type Hypersensitivity Skin Test Responses and Immunogenicity in Asymptomatic HIV Seropositive Patients With More Than 400 CD4 Cells
|
View
|
NCT00000666 |
|
A Randomized Prospective Study of Pyrimethamine Therapy for Prevention of Toxoplasmic Encephalitis in HIV-Infected Individuals With Serologic Evidence of Latent Toxoplasma Gondii Infection
|
View
|
NCT00000665 |
|
Studies of the Ocular Complications of AIDS SOCA CMV Retinitis Trial Foscarnet-Ganciclovir Component
|
View
|
NCT00000664 |
|
Safety and Efficacy of Polyethylene Glycolated IL-2 PEG IL-2 Plus Zidovudine in HIV Positive Asymptomatic and Symptomatic Individuals
|
View
|
NCT00000663 |
|
A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G rCD4-IgG in Infants and Children With Documented HIV-1 Infection
|
View
|
NCT00000662 |
|
A Treatment IND for Retrovir Brand Zidovudine AZT Therapy of Pediatric Patients With HIV Disease
|
View
|
NCT00000661 |
|
The Pharmacokinetics of Zidovudine and Oxazepam Alone and in Combination in the HIV-Infected Patient
|
View
|
NCT00000660 |
|
Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposis Sarcoma
|
View
|
NCT00000659 |
|
A Phase II Trial of rsCD4 and AZT in Patients With AIDS or Advanced AIDS Related Complex ARC
|
View
|
NCT00000658 |
|
A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkins Lymphoma
|
View
|
NCT00000657 |
|
Comparison of 23-Dideoxyinosine Didanosine ddI and Zidovudine in Therapy of Patients With the AIDS Dementia Complex
|
View
|
NCT00000656 |
|
A Phase III Open Label Study to Evaluate the Antiviral Potential of Combination Zidovudine and 2 3-Dideoxyinosine Didanosine in Patients With Asymptomatic HIV Disease
|
View
|
NCT00000655 |
|
A Randomized Double-Blind Study of 566C80 Versus Septra SulfamethoxazoleTrimethoprim for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients
|
View
|
NCT00000654 |
|
The Tolerance of HIV-Infected Patients With Herpes Group Virus Infections to Oral Doses of FIAU
|
View
|
NCT00000653 |
|
A Trial of Two Doses of 23-Dideoxycytidine ddC in the Treatment of Children With Symptomatic HIV Infection Who Are Intolerant of AZT andor Who Show Progressive Disease While on AZT
|
View
|
NCT00000652 |
|
A Phase I Study to Evaluate the Safety and Toxicity of the Combination of Zidovudine and 23-Dideoxyinosine Didanosine in Children With HIV Infection
|
View
|
NCT00000651 |
|
A Randomized Double Blind Comparative Study of Dideoxycytidine ddC Alone or ddCAZT Combination Versus Zidovudine ZDV Alone in Patients With HIV Infection Who Have Received Prior ZDV Therapy
|
View
|
NCT00000650 |
|
An Assessment of the In Vivo Biological Effects of Diethyldithiocarbamate DTC in HIV-Infected Patients
|
View
|
NCT00000649 |
|
An Open-Label Staggered Rising Dose Cohort Study Assessing the Pharmacokinetics Safety and Tolerance of BI-RG-587 in Combination With Zidovudine in Patients With HIV Infection CD4 Cell Count 400mm3
|
View
|
NCT00000648 |
|
A Pilot Study Evaluating Penicillin G and Ceftriaxone as Therapies for Presumed Neurosyphilis in HIV Seropositive Individuals
|
View
|
NCT00000647 |
|
An Open Trial Combining Zidovudine Interferon-alfa and Recombinant CD4-IgG With Transplantation of Syngeneic Bone Marrow and Peripheral Blood Lymphocytes From Healthy gp160-Immunized Donors in the Treatment of Patients With HIV Infection
|
View
|
NCT00000646 |
|
Pentoxifylline Trental as a Modulator of Tumor Necrosis Factor and of HIV Replication in Patients With AIDS
|
View
|
NCT00000645 |
|
A Phase I Dose Escalation Study of Synthetic Hypericin in HIV-Infected Patients With Less Than 300 CD4 Lymphocytes
|
View
|
NCT00000644 |
|
A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Disseminated M Avium Complex MAC Infections in Patients With AIDS
|
View
|
NCT00000643 |
|
Primary Prophylaxis of Cerebral Toxoplasmosis in HIV-Infected Patients
|
View
|
NCT00000642 |
|
A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G rCD4-IgG in HIV-1 Seropositive Women During the Last Trimester of Pregnancy and Their Newborns
|
View
|
NCT00000641 |
|
A Phase IIIII Trial of Rifampin Ciprofloxacin Clofazimine Ethambutol and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals
|
View
|
NCT00000640 |
|
A Phase III Comparative Study of Dapsone Trimethoprim and Clindamycin Primaquine Versus Sulfamethoxazole Trimethoprim in the Treatment of Mild-to-Moderate PCP in Patients With AIDS
|
View
|
NCT00000639 |
|
A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to Amphotericin B Alone Followed by a Comparison of Fluconazole and Itraconazole in the Treatment of Acute Cryptococcal Meningitis
|
View
|
NCT00000638 |
|
Preventive Treatment Against Tuberculosis TB in Patients With Human Immunodeficiency Virus HIV Infection and Confirmed Latent Tuberculous Infection
|
View
|
NCT00000637 |
|
A Randomized Comparative Trial of Zidovudine AZT Versus 23-Dideoxyinosine ddI Versus AZT Plus ddI in Symptomatic HIV-Infected Children
|
View
|
NCT00000636 |
|
Prophylaxis Against Tuberculosis TB in Patients With Human Immunodeficiency Virus HIV Infection and Confirmed Latent Tuberculous Infection
|
View
|
NCT00000635 |
|
Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex Disease in Patients With AIDS Open Label Pilot Study of Topical Trifluridine
|
View
|
NCT00000634 |
|
A Pilot Pharmacokinetic Phase I Evaluation of BI-RG-587 in HIV-Infected Children
|
View
|
NCT00000633 |
|
A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Immuno-AG Recombinant HIV gp160 in Asymptomatic HIV Seropositive Individuals
|
View
|
NCT00000632 |
|
A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 100 mcg of Env 2-3 in MF59
|
View
|
NCT00000631 |
|
A Phase I Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-HIV Envelope Recombinant Vaccine HIVAC-1e in Combination With Soluble Recombinant Envelope Vaccine VaxSyn
|
View
|
NCT00000630 |
|
Phase I Safety and Immunogenicity Trial of Vaccinia-HIV Envelope Recombinant Vaccine HIVAC-1e in Combination With Soluble Recombinant Envelope Vaccine gp160 VaxSyn
|
View
|
NCT00000629 |
|
The Effects of Valproic Acid on Zidovudine Glucuronidation and Pharmacokinetics in HIV-Infected Patients
|
View
|
NCT00000628 |
|
A Pharmacokinetic Study of L-697661 Alone and in Combination With Zidovudine
|
View
|
NCT00000627 |
|
Pilot Study to Determine the Feasibility of Fluconazole for Induction Treatment and Suppression of Relapse of Histoplasmosis in Patients With the Acquired Immunodeficiency Syndrome
|
View
|
NCT00000626 |
|
Phase II Study of Filgrastim G-CSF Plus ABVD in the Treatment of HIV-Associated Hodgkins Disease
|
View
|
NCT00000625 |
|
A Randomized Double-Blind Phase IIIII Trial of Monotherapy vs Combination Therapy With Nucleoside Analogs in HIV-Infected Persons With CD4 Cells of 200-500mm3
|
View
|
NCT00000623 |
|
Thalassemia Cooleys Anemia Clinical Research Network TCRN
|
View
|
NCT00000621 |
|
Feasibility of Retinoic Acid Treatment in Emphysema FORTE
|
View
|
NCT00000620 |
|
Action to Control Cardiovascular Risk in Diabetes ACCORD
|
View
|
NCT00000619 |
|
Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness ESCAPE
|
View
|
NCT00000617 |
|
Azithromycin and Coronary Events Study ACES
|
View
|
NCT00000616 |
|
PREMIER Lifestyle Interventions for Blood Pressure Control
|
View
|
NCT00000615 |
|
Girls Health Enrichment Multi-Site Studies GEMS
|
View
|
NCT00000614 |
|
Prevention of Recurrent Venous Thromboembolism PREVENT
|
View
|
NCT00000613 |
|
CVD Risk and Health in Postmenopausal Phytoestrogen Users
|
View
|
NCT00000612 |
|
Soy Estrogen Alternative Study SEA
|
View
|
NCT00000611 |
|
Womens Health Initiative WHI
|
View
|
NCT00000610 |
|
Magnesium in Coronaries MAGIC
|
View
|
NCT00000609 |
|
Sudden Cardiac Death in Heart Failure Trial SCD-HeFT
|
View
|
NCT00000608 |
|
Dietary Patterns Sodium Intake and Blood Pressure DASH - Sodium
|
View
|